Select a Region North America

EVERSANA’s Direct-to-Patient Care Model

A Direct-to-Patient Mindset and Model Emerges

Fact: Despite technological advances, patients are still waiting months to see a provider and their treatment journeys are fraught with delays, complexity and frustration. Additionally, the traditional commercialization model is fragmented, inefficient and restrictive, leading to significant delays in patients’ access to treatment and script lift.

Patients and brand teams expect – and deserve – better.

EVERSANA’s fully integrated Direct-to-Patient Model is proven to drive brand adoption and enhance the patients’ experience with pharma brands throughout their treatment journey – from diagnosis to affordability and long-term adherence.

As the industry’s first and only patient-led, fully integrated care model, EVERSANA is accelerating patients’ access to providers and treatments. By combining the forces of social media targeting, advertising, specialized field deployment, telehealth, pharmacy billing, benefit verification and dispensing, this commercial model is truly disrupting the ecosystem.

By providing a patient-facing, technology-enabled model – as one channel within the overall commercialization strategy – brand teams can help to eliminate patient access, affordability and adherence barriers. DTP should now be recognized as a strategic commercial model that enhances operational efficiency, reduces costs, and supports patients throughout their treatment journey.

The Promise of a Direct-to-Patient Model

Breaking Down What’s Really Needed for Better Patient Access

Discover the benefits of EVERSANA’s Direct-to-Patient Model.

  • Streamline Patient Access, Engagement, Treatment Initiation and Adherence Learn More
  • Drive Brand Promotion, HCP Adoption and Patient Fulfillment Learn More
  • Generate Real-Time Data and Actionable Insights Across the Product Life Cycle Learn More

Contact Us

Schedule a meeting today!